{"transactions":[{"id":4619062,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-16T18:00:36.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":4.8195,"value":120487.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involves sale transactions from $4.78 to $4.90 per share. The weighted average price per share was $4.8195. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":652317,"source":{"system":"sec-edgar","filing":"0001214659-26-011731","document":"marketforms-73998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742266/000121465926011731/marketforms-73998.xml","form_type":"4"}},{"id":4615630,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-09-11T15:07:53.000Z","date":"2026-09-09","kind":"exercise","planned":true,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":26250,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001214659-26-011596","document":"marketforms-73981.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926011596/marketforms-73981.xml","form_type":"4"}},{"id":4615629,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T15:07:53.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":8750,"price":5.22,"value":45675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":235689,"source":{"system":"sec-edgar","filing":"0001214659-26-011596","document":"marketforms-73981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926011596/marketforms-73981.xml","form_type":"4"}},{"id":4615628,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T15:07:53.000Z","date":"2026-09-09","kind":"exercise","planned":true,"acquired":true,"shares":8750,"price":2.65,"value":23187.5,"ownership":{"direct":true},"balance_after":244439,"source":{"system":"sec-edgar","filing":"0001214659-26-011596","document":"marketforms-73981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926011596/marketforms-73981.xml","form_type":"4"}},{"id":4614390,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2026-09-10T13:21:32.000Z","date":"2026-09-09","kind":"other","planned":false,"acquired":false,"shares":2293,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.96,"exercise_date":"2022-12-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":2293},"source":{"system":"sec-edgar","filing":"0001214659-26-011541","document":"marketforms-73978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739816/000121465926011541/marketforms-73978.xml","form_type":"4"}},{"id":4614389,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-09-10T13:21:32.000Z","date":"2026-09-09","kind":"other","planned":false,"acquired":true,"shares":2293,"price":0.96,"value":2201.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."}],"balance_after":284024,"source":{"system":"sec-edgar","filing":"0001214659-26-011541","document":"marketforms-73978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739816/000121465926011541/marketforms-73978.xml","form_type":"4"}},{"id":4613566,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant (Right to Buy)","published_at":"2026-09-09T21:10:52.000Z","date":"2026-09-08","kind":"other","planned":false,"acquired":false,"shares":91743,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.96,"exercise_date":"2022-12-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":91743},"source":{"system":"sec-edgar","filing":"0001214659-26-011539","document":"marketforms-73974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1742266/000121465926011539/marketforms-73974.xml","form_type":"4"}},{"id":4613565,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-09T21:10:52.000Z","date":"2026-09-08","kind":"other","planned":false,"acquired":true,"shares":91743,"price":0.96,"value":88073.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."}],"balance_after":677317,"source":{"system":"sec-edgar","filing":"0001214659-26-011539","document":"marketforms-73974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742266/000121465926011539/marketforms-73974.xml","form_type":"4"}},{"id":3513555,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2026-09-08T20:06:19.000Z","date":"2026-09-03","kind":"other","planned":false,"acquired":false,"shares":4587,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.96,"exercise_date":"2022-12-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":4587},"source":{"system":"sec-edgar","filing":"0001214659-26-011475","document":"marketforms-73943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1960154/000121465926011475/marketforms-73943.xml","form_type":"4"}},{"id":3513554,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:06:19.000Z","date":"2026-09-03","kind":"other","planned":false,"acquired":true,"shares":4587,"price":0.96,"value":4403.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."}],"balance_after":206833,"source":{"system":"sec-edgar","filing":"0001214659-26-011475","document":"marketforms-73943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1960154/000121465926011475/marketforms-73943.xml","form_type":"4"}},{"id":683005,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-18T20:13:12.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":4.2867,"value":107167.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involves sale transactions from $4.24 to $4.35 per share. The weighted average price per share was $4.2867. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":585574,"source":{"system":"sec-edgar","filing":"0001214659-26-010516","document":"marketforms-73780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926010516/marketforms-73780.xml","form_type":"4"}},{"id":685787,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-17T21:33:35.000Z","date":"2026-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2714,"price":4.25,"value":11534.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":235689,"source":{"system":"sec-edgar","filing":"0001214659-26-010474","document":"marketforms-73774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926010474/marketforms-73774.xml","form_type":"4"}},{"id":706490,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-17T17:15:32.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":20369,"price":4.0016,"value":81508.5904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involves sale transactions from $4.00 to $4.01 per share. The weighted average price per share was $4.00016. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":610574,"source":{"system":"sec-edgar","filing":"0001214659-26-008663","document":"marketforms-73615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926008663/marketforms-73615.xml","form_type":"4"}},{"id":706489,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-17T17:15:32.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":4631,"price":4.0344,"value":18683.3064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involves sale transactions from $4.00 to $4.04 per share. The weighted average price per share was $4.0344. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":630943,"source":{"system":"sec-edgar","filing":"0001214659-26-008663","document":"marketforms-73615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926008663/marketforms-73615.xml","form_type":"4"}},{"id":727615,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-24T15:11:33.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 22, 2022 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.7132,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-26-007677","document":"marketforms-73450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007677/marketforms-73450.xml","form_type":"4"}},{"id":727614,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T15:11:33.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5.0157,"value":125392.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-26-007677","document":"marketforms-73450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007677/marketforms-73450.xml","form_type":"4"}},{"id":727613,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T15:11:33.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.7132,"value":17830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001214659-26-007677","document":"marketforms-73450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007677/marketforms-73450.xml","form_type":"4"}},{"id":735929,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-16T20:09:00.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":4.1604,"value":104010.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involves sale transactions from $4.14 to $4.235 per share. The weighted average price per share was $4.1604. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":635574,"source":{"system":"sec-edgar","filing":"0001214659-26-007511","document":"marketforms-73405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926007511/marketforms-73405.xml","form_type":"4"}},{"id":739795,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T15:43:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007398","document":"marketforms-73384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007398/marketforms-73384.xml","form_type":"4"}},{"id":739308,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-12T15:42:54.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":false,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007397","document":"marketforms-73383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926007397/marketforms-73383.xml","form_type":"4"}},{"id":739603,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T15:42:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007396","document":"marketforms-73382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465926007396/marketforms-73382.xml","form_type":"4"}},{"id":739452,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38639,"kind":"person","name":"MORRIS TIMOTHY E","position":1,"cik":"0001191286","reported_name":"MORRIS TIMOTHY E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2026-06-12T11:43:26.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007399","document":"marketforms-73385.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191286/000121465926007399/marketforms-73385.xml","form_type":"4"}},{"id":739354,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T11:42:23.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007395","document":"marketforms-73381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465926007395/marketforms-73381.xml","form_type":"4"}},{"id":739605,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T11:42:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007394","document":"marketforms-73386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465926007394/marketforms-73386.xml","form_type":"4"}},{"id":744962,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T18:48:07.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":238403,"source":{"system":"sec-edgar","filing":"0001214659-26-007262","document":"marketforms-73366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926007262/marketforms-73366.xml","form_type":"4"}},{"id":771421,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":45933,"kind":"person","name":"Zalewski Thomas A.","position":1,"cik":"0002127796","reported_name":"Zalewski Thomas A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-19T16:02:01.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":75000,"derivative":{"exercise_price":4.135,"expiration_date":"2036-05-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-26-006554","document":"marketforms-73026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926006554/marketforms-73026.xml","form_type":"4"}},{"id":771420,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":45933,"kind":"person","name":"Zalewski Thomas A.","position":1,"cik":"0002127796","reported_name":"Zalewski Thomas A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-19T16:02:01.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001214659-26-006554","document":"marketforms-73026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926006554/marketforms-73026.xml","form_type":"4"}},{"id":774487,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-18T18:03:23.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":8257,"price":4.2889,"value":35413.4473,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involves sale transactions from $4.17 to $4.64 per share. The weighted average price per share was $4.2889. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":660574,"source":{"system":"sec-edgar","filing":"0001214659-26-006532","document":"marketforms-73192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926006532/marketforms-73192.xml","form_type":"4"}},{"id":774484,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":46346,"kind":"person","name":"Cioffi Melina","position":1,"cik":"0002066841","reported_name":"Cioffi Melina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Common Stock","published_at":"2026-05-18T16:36:51.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1667,"price":4.17,"value":6951.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":273200,"source":{"system":"sec-edgar","filing":"0001214659-26-006527","document":"marketforms-73191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926006527/marketforms-73191.xml","form_type":"4"}},{"id":784406,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-05-11T20:35:43.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":135690,"price":4.23,"value":573968.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":231042,"source":{"system":"sec-edgar","filing":"0001214659-26-005932","document":"marketforms-73160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005932/marketforms-73160.xml","form_type":"4"}},{"id":788316,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-05-07T21:34:07.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":56778,"price":4.18,"value":237332.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":281731,"source":{"system":"sec-edgar","filing":"0001214659-26-005751","document":"marketforms-73068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005751/marketforms-73068.xml","form_type":"4"}},{"id":788315,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-07T21:33:52.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":335922,"price":4.18,"value":1404153.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":668831,"source":{"system":"sec-edgar","filing":"0001214659-26-005750","document":"marketforms-73067.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005750/marketforms-73067.xml","form_type":"4"}},{"id":788385,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49089,"kind":"person","name":"TOTH A ERNEST JR","position":1,"cik":"0001280273","reported_name":"TOTH A ERNEST JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-07T21:33:37.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":92652,"price":4.18,"value":387285.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":283460,"source":{"system":"sec-edgar","filing":"0001214659-26-005749","document":"marketforms-73071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280273/000121465926005749/marketforms-73071.xml","form_type":"4"}},{"id":788314,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-07T21:32:25.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":72734,"price":4.18,"value":304028.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":202246,"source":{"system":"sec-edgar","filing":"0001214659-26-005748","document":"marketforms-73070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005748/marketforms-73070.xml","form_type":"4"}},{"id":788313,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Secretary"}}],"security":"Common Stock","published_at":"2026-05-07T21:31:34.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":76147,"price":4.18,"value":318294.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":366732,"source":{"system":"sec-edgar","filing":"0001214659-26-005747","document":"marketforms-73069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005747/marketforms-73069.xml","form_type":"4"}},{"id":809526,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:54:35.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":293100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":293100,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":293100},"source":{"system":"sec-edgar","filing":"0001214659-26-004597","document":"marketforms-72912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926004597/marketforms-72912.xml","form_type":"4"}},{"id":809527,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:54:06.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":60000,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-004596","document":"marketforms-72925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926004596/marketforms-72925.xml","form_type":"4"}},{"id":809525,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:53:34.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":60000,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-004595","document":"marketforms-72927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926004595/marketforms-72927.xml","form_type":"4"}},{"id":809576,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49089,"kind":"person","name":"TOTH A ERNEST JR","position":1,"cik":"0001280273","reported_name":"TOTH A ERNEST JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:52:58.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":82500,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001214659-26-004594","document":"marketforms-72932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280273/000121465926004594/marketforms-72932.xml","form_type":"4"}},{"id":809763,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:52:27.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":67500,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001214659-26-004593","document":"marketforms-72933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926004593/marketforms-72933.xml","form_type":"4"}},{"id":809524,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Secretary"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:51:56.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":82500,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001214659-26-004592","document":"marketforms-72926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926004592/marketforms-72926.xml","form_type":"4"}},{"id":848351,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:52:57.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":4.29,"value":182325.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":42500,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001214659-26-003147","document":"marketforms-72463.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003147/marketforms-72463.xml","form_type":"4"}},{"id":848350,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:57.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":29814,"price":4.173,"value":124413.822,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":338509,"source":{"system":"sec-edgar","filing":"0001214659-26-003147","document":"marketforms-72463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003147/marketforms-72463.xml","form_type":"4"}},{"id":848349,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:57.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":368323,"source":{"system":"sec-edgar","filing":"0001214659-26-003147","document":"marketforms-72463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003147/marketforms-72463.xml","form_type":"4"}},{"id":848357,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:52:40.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":523000,"price":4.29,"value":2243670.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":523000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":523000},"source":{"system":"sec-edgar","filing":"0001214659-26-003146","document":"marketforms-72462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003146/marketforms-72462.xml","form_type":"4"}},{"id":848356,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:40.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":180677,"price":4.173,"value":753965.121,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by\nthe Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1004753,"source":{"system":"sec-edgar","filing":"0001214659-26-003146","document":"marketforms-72462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003146/marketforms-72462.xml","form_type":"4"}},{"id":848355,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:40.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":262000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":1185430,"source":{"system":"sec-edgar","filing":"0001214659-26-003146","document":"marketforms-72462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003146/marketforms-72462.xml","form_type":"4"}},{"id":848354,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:52:26.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":4.29,"value":214500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-26-003145","document":"marketforms-72464.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003145/marketforms-72464.xml","form_type":"4"}},{"id":848353,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:26.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":40102,"price":4.173,"value":167345.646,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":442879,"source":{"system":"sec-edgar","filing":"0001214659-26-003145","document":"marketforms-72464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003145/marketforms-72464.xml","form_type":"4"}},{"id":848352,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":48292,"kind":"person","name":"BRAENDER LORI J","position":1,"cik":"0001752955","reported_name":"BRAENDER LORI J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:26.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":482981,"source":{"system":"sec-edgar","filing":"0001214659-26-003145","document":"marketforms-72464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003145/marketforms-72464.xml","form_type":"4"}},{"id":848345,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":46346,"kind":"person","name":"Cioffi Melina","position":1,"cik":"0002066841","reported_name":"Cioffi Melina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:52:15.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":4.29,"value":321750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":75000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-26-003144","document":"marketforms-72465.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003144/marketforms-72465.xml","form_type":"4"}},{"id":848344,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":46346,"kind":"person","name":"Cioffi Melina","position":1,"cik":"0002066841","reported_name":"Cioffi Melina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:15.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":25311,"price":4.173,"value":105622.803,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":274867,"source":{"system":"sec-edgar","filing":"0001214659-26-003144","document":"marketforms-72465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003144/marketforms-72465.xml","form_type":"4"}},{"id":848343,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":46346,"kind":"person","name":"Cioffi Melina","position":1,"cik":"0002066841","reported_name":"Cioffi Melina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Common Stock","published_at":"2026-03-11T16:52:15.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":300178,"source":{"system":"sec-edgar","filing":"0001214659-26-003144","document":"marketforms-72465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003144/marketforms-72465.xml","form_type":"4"}},{"id":848511,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49089,"kind":"person","name":"TOTH A ERNEST JR","position":1,"cik":"0001280273","reported_name":"TOTH A ERNEST JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:51:44.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":70000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001214659-26-003143","document":"marketforms-72470.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280273/000121465926003143/marketforms-72470.xml","form_type":"4"}},{"id":848510,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49089,"kind":"person","name":"TOTH A ERNEST JR","position":1,"cik":"0001280273","reported_name":"TOTH A ERNEST JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:51:44.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":58254,"price":4.173,"value":243093.942,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":376112,"source":{"system":"sec-edgar","filing":"0001214659-26-003143","document":"marketforms-72470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280273/000121465926003143/marketforms-72470.xml","form_type":"4"}},{"id":848509,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49089,"kind":"person","name":"TOTH A ERNEST JR","position":1,"cik":"0001280273","reported_name":"TOTH A ERNEST JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:51:44.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":434366,"source":{"system":"sec-edgar","filing":"0001214659-26-003143","document":"marketforms-72470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280273/000121465926003143/marketforms-72470.xml","form_type":"4"}},{"id":849098,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:51:23.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":4.29,"value":182325.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":42500,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001214659-26-003142","document":"marketforms-72468.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926003142/marketforms-72468.xml","form_type":"4"}},{"id":849097,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:51:23.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":15741,"price":4.173,"value":65687.193,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":241117,"source":{"system":"sec-edgar","filing":"0001214659-26-003142","document":"marketforms-72468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926003142/marketforms-72468.xml","form_type":"4"}},{"id":849096,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:51:23.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":256858,"source":{"system":"sec-edgar","filing":"0001214659-26-003142","document":"marketforms-72468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926003142/marketforms-72468.xml","form_type":"4"}},{"id":848348,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:50:43.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":42500,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001214659-26-003141","document":"marketforms-72467.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003141/marketforms-72467.xml","form_type":"4"}},{"id":848347,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:50:43.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":45791,"price":4.173,"value":191085.843,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":274980,"source":{"system":"sec-edgar","filing":"0001214659-26-003141","document":"marketforms-72467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003141/marketforms-72467.xml","form_type":"4"}},{"id":848346,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:50:43.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":320771,"source":{"system":"sec-edgar","filing":"0001214659-26-003141","document":"marketforms-72467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003141/marketforms-72467.xml","form_type":"4"}},{"id":848342,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:49:56.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-26-003140","document":"marketforms-72466.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003140/marketforms-72466.xml","form_type":"4"}},{"id":848341,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:49:56.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001214659-26-003140","document":"marketforms-72466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003140/marketforms-72466.xml","form_type":"4"}},{"id":848340,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61478,"kind":"person","name":"Greenhawt Matthew J.","position":1,"cik":"0002113518","reported_name":"Greenhawt Matthew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T13:25:59.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":4.29,"value":214500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-26-003134","document":"marketforms-72376.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003134/marketforms-72376.xml","form_type":"4"}},{"id":848339,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61478,"kind":"person","name":"Greenhawt Matthew J.","position":1,"cik":"0002113518","reported_name":"Greenhawt Matthew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-11T13:25:59.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001214659-26-003134","document":"marketforms-72376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003134/marketforms-72376.xml","form_type":"4"}},{"id":978797,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-12-05T18:06:06.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":288323,"source":{"system":"sec-edgar","filing":"0001214659-25-017652","document":"marketforms-71415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925017652/marketforms-71415.xml","form_type":"4"}},{"id":980044,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":46346,"kind":"person","name":"Cioffi Melina","position":1,"cik":"0002066841","reported_name":"Cioffi Melina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Common Stock","published_at":"2025-12-04T15:39:37.000Z","date":"2025-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2083,"price":5.93,"value":12352.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":200178,"source":{"system":"sec-edgar","filing":"0001214659-25-017591","document":"marketforms-71360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925017591/marketforms-71360.xml","form_type":"4"}},{"id":1001643,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-12T14:35:57.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":5.58,"expiration_date":"2035-11-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-25-016275","document":"marketforms-71182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925016275/marketforms-71182.xml","form_type":"4"}},{"id":1001642,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-12T14:35:57.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001214659-25-016275","document":"marketforms-71182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925016275/marketforms-71182.xml","form_type":"4"}},{"id":1016387,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-10-17T18:01:41.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 10, 2021 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.1027,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-25-015048","document":"marketforms-71051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015048/marketforms-71051.xml","form_type":"4"}},{"id":1016386,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-10-17T18:01:41.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":67575,"price":7.01,"value":473700.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":240771,"source":{"system":"sec-edgar","filing":"0001214659-25-015048","document":"marketforms-71051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015048/marketforms-71051.xml","form_type":"4"}},{"id":1016385,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-10-17T18:01:41.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.1027,"value":77567.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":308346,"source":{"system":"sec-edgar","filing":"0001214659-25-015048","document":"marketforms-71051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015048/marketforms-71051.xml","form_type":"4"}},{"id":1016384,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":74153,"kind":"person","name":"Kraus Carl N","position":1,"cik":"0001946475","reported_name":"Kraus Carl N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T18:01:00.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":20272,"price":7,"value":141904.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involves sale transactions from $7.00 to $7.02 per share. The weighted average price per share was $7.00. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":282475,"source":{"system":"sec-edgar","filing":"0001214659-25-015047","document":"marketforms-71050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015047/marketforms-71050.xml","form_type":"4"}},{"id":1016383,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-17T18:00:39.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":7,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":268323,"source":{"system":"sec-edgar","filing":"0001214659-25-015046","document":"marketforms-71047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015046/marketforms-71047.xml","form_type":"4"}},{"id":1031103,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-29T20:26:26.000Z","date":"2025-09-26","kind":"sale","planned":true,"acquired":false,"shares":91343,"price":6.0343,"value":551191.0649,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involves sale transactions from $6.00 to $6.11 per share. The weighted average price per share was $6.0343. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price."}],"balance_after":923430,"source":{"system":"sec-edgar","filing":"0001214659-25-014288","document":"marketforms-70872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925014288/marketforms-70872.xml","form_type":"4"}},{"id":1031102,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-29T20:26:10.000Z","date":"2025-09-26","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":6.3,"value":63000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":278323,"source":{"system":"sec-edgar","filing":"0001214659-25-014287","document":"marketforms-70873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925014287/marketforms-70873.xml","form_type":"4"}},{"id":1034245,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22102,"kind":"person","name":"Barber Daniel","position":1,"cik":"0001742266","reported_name":"Barber Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-22T21:25:21.000Z","date":"2025-09-19","kind":"sale","planned":true,"acquired":false,"shares":400,"price":6,"value":2400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":1014773,"source":{"system":"sec-edgar","filing":"0001214659-25-014009","document":"marketforms-70823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925014009/marketforms-70823.xml","form_type":"4"}},{"id":1045639,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on August 5, 2022 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.7063,"expiration_date":"2032-08-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045638,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on August 9, 2019 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.15,"expiration_date":"2029-08-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045637,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"sale","planned":true,"acquired":false,"shares":62180,"price":5,"value":310900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":283346,"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045636,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.7063,"value":17657.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":345526,"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045635,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.15,"value":78750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":320526,"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045624,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49072,"kind":"person","name":"Boyd Peter E.","position":1,"cik":"0001739816","reported_name":"Boyd Peter E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-08T21:13:13.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":5.3,"value":79500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":288323,"source":{"system":"sec-edgar","filing":"0001214659-25-013485","document":"marketforms-70566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013485/marketforms-70566.xml","form_type":"4"}},{"id":1065556,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T12:41:12.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":181858,"source":{"system":"sec-edgar","filing":"0001214659-25-012304","document":"marketforms-70071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925012304/marketforms-70071.xml","form_type":"4"}},{"id":1068628,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":74153,"kind":"person","name":"Kraus Carl N","position":1,"cik":"0001946475","reported_name":"Kraus Carl N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-12T14:11:01.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10819,"price":3.9,"value":42194.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":302747,"source":{"system":"sec-edgar","filing":"0001214659-25-011823","document":"marketforms-70221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925011823/marketforms-70221.xml","form_type":"4"}},{"id":1113320,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T17:59:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009123","document":"marketforms-69482.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465925009123/marketforms-69482.xml","form_type":"4"}},{"id":1112969,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-12T17:59:05.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":false,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009121","document":"marketforms-69481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925009121/marketforms-69481.xml","form_type":"4"}},{"id":1113181,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T17:58:00.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009120","document":"marketforms-69480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465925009120/marketforms-69480.xml","form_type":"4"}},{"id":1112983,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38604,"kind":"person","name":"BROWN GREGORY B","position":1,"cik":"0001373585","reported_name":"BROWN GREGORY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T14:13:31.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009128","document":"marketforms-69477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373585/000121465925009128/marketforms-69477.xml","form_type":"4"}},{"id":1113075,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38639,"kind":"person","name":"MORRIS TIMOTHY E","position":1,"cik":"0001191286","reported_name":"MORRIS TIMOTHY E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-06-12T13:59:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009122","document":"marketforms-69483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191286/000121465925009122/marketforms-69483.xml","form_type":"4"}},{"id":1113182,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T13:57:23.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009118","document":"marketforms-69475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465925009118/marketforms-69475.xml","form_type":"4"}},{"id":1116616,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Sales and Marketing"}}],"security":"Common Stock","published_at":"2025-06-10T18:12:59.000Z","date":"2025-06-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2714,"price":3.54,"value":9607.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":156858,"source":{"system":"sec-edgar","filing":"0001214659-25-009047","document":"marketforms-69905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925009047/marketforms-69905.xml","form_type":"4"}},{"id":1147056,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":46346,"kind":"person","name":"Cioffi Melina","position":1,"cik":"0002066841","reported_name":"Cioffi Melina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Common Stock","published_at":"2025-05-15T16:59:30.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":202261,"source":{"system":"sec-edgar","filing":"0001214659-25-007749","document":"marketforms-69454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925007749/marketforms-69454.xml","form_type":"4"}},{"id":1211734,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":65000,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211733,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4572,"price":2.54,"value":11612.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":343552,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211732,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":15431,"price":2.65,"value":40892.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":348124,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211731,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":12859,"price":2.65,"value":34076.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":363555,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211730,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":376414,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211729,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-11T21:48:57.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":40000,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001214659-25-004227","document":"marketforms-68571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004227/marketforms-68571.xml","form_type":"4"}}],"next_cursor":"2025-03-11T21:48:57.000000Z,1211729"}